灭活疫苗对H9N2禽流感病毒在鸡群中传播和进化的影响

IF 6.9 1区 医学 Q1 IMMUNOLOGY
Zhe Hu, Hui Ai, Zhen Wang, Shiyue Huang, Honglei Sun, Xinxin Xuan, Mingyue Chen, Jinxiu Wang, Wei Yan, Jiayi Sun, Juan Pu, Christopher B Brooke, Kin-Chow Chang, Yipeng Sun, Jinhua Liu
{"title":"灭活疫苗对H9N2禽流感病毒在鸡群中传播和进化的影响","authors":"Zhe Hu, Hui Ai, Zhen Wang, Shiyue Huang, Honglei Sun, Xinxin Xuan, Mingyue Chen, Jinxiu Wang, Wei Yan, Jiayi Sun, Juan Pu, Christopher B Brooke, Kin-Chow Chang, Yipeng Sun, Jinhua Liu","doi":"10.1038/s41541-025-01115-y","DOIUrl":null,"url":null,"abstract":"<p><p>H9N2 avian influenza virus (AIV) is endemic in poultry worldwide and increasingly zoonotic. Despite the long-term widespread use of inactivated vaccines, H9N2 AIVs remain dominant in chicken flocks. We demonstrated that inactivated vaccines did not prevent the replication of H9N2 AIVs in the upper airway of vaccinated chickens. Viral transmission was enhanced during sequential passage in vaccinated chickens, which was attributed to the restricted production of defective interfering particles and the introduction of stable mutations (NP-N417D, M1-V219I, and NS1-R140W) which enhanced viral replication. Notably, the genetic diversity of H9N2 AIVs was greater and included more potential mammal/human-adapted mutations after passage through vaccinated chickens than through naïve chickens, which might facilitate the emergence of mammal-adapted strains. By contrast, vaccines inducing cellular/mucosal immunity in the upper respiratory tract effectively limit H9N2 AIV. These findings highlight the limitations of inactivated vaccines and the need for revised vaccination strategies to control H9N2 AIV.</p>","PeriodicalId":19335,"journal":{"name":"NPJ Vaccines","volume":"10 1","pages":"67"},"PeriodicalIF":6.9000,"publicationDate":"2025-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11971428/pdf/","citationCount":"0","resultStr":"{\"title\":\"Impact of inactivated vaccine on transmission and evolution of H9N2 avian influenza virus in chickens.\",\"authors\":\"Zhe Hu, Hui Ai, Zhen Wang, Shiyue Huang, Honglei Sun, Xinxin Xuan, Mingyue Chen, Jinxiu Wang, Wei Yan, Jiayi Sun, Juan Pu, Christopher B Brooke, Kin-Chow Chang, Yipeng Sun, Jinhua Liu\",\"doi\":\"10.1038/s41541-025-01115-y\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>H9N2 avian influenza virus (AIV) is endemic in poultry worldwide and increasingly zoonotic. Despite the long-term widespread use of inactivated vaccines, H9N2 AIVs remain dominant in chicken flocks. We demonstrated that inactivated vaccines did not prevent the replication of H9N2 AIVs in the upper airway of vaccinated chickens. Viral transmission was enhanced during sequential passage in vaccinated chickens, which was attributed to the restricted production of defective interfering particles and the introduction of stable mutations (NP-N417D, M1-V219I, and NS1-R140W) which enhanced viral replication. Notably, the genetic diversity of H9N2 AIVs was greater and included more potential mammal/human-adapted mutations after passage through vaccinated chickens than through naïve chickens, which might facilitate the emergence of mammal-adapted strains. By contrast, vaccines inducing cellular/mucosal immunity in the upper respiratory tract effectively limit H9N2 AIV. These findings highlight the limitations of inactivated vaccines and the need for revised vaccination strategies to control H9N2 AIV.</p>\",\"PeriodicalId\":19335,\"journal\":{\"name\":\"NPJ Vaccines\",\"volume\":\"10 1\",\"pages\":\"67\"},\"PeriodicalIF\":6.9000,\"publicationDate\":\"2025-04-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11971428/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"NPJ Vaccines\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1038/s41541-025-01115-y\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"NPJ Vaccines","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41541-025-01115-y","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

H9N2禽流感病毒(AIV)在世界范围内的家禽中流行,并日益人畜共患。尽管长期广泛使用灭活疫苗,但H9N2 aiv在鸡群中仍占主导地位。我们证明了灭活疫苗不能阻止H9N2 aiv在接种鸡上呼吸道的复制。在接种疫苗的鸡中,病毒在顺序传代过程中传播增强,这是由于缺陷干扰颗粒的限制产生和稳定突变(NP-N417D、M1-V219I和NS1-R140W)的引入增强了病毒的复制。值得注意的是,与naïve鸡相比,H9N2 aiv通过接种鸡的遗传多样性更大,包含更多潜在的哺乳动物/人类适应突变,这可能促进了哺乳动物适应菌株的出现。相比之下,在上呼吸道诱导细胞/粘膜免疫的疫苗有效地限制了H9N2 AIV。这些发现强调了灭活疫苗的局限性以及修订疫苗接种策略以控制H9N2 AIV的必要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Impact of inactivated vaccine on transmission and evolution of H9N2 avian influenza virus in chickens.

H9N2 avian influenza virus (AIV) is endemic in poultry worldwide and increasingly zoonotic. Despite the long-term widespread use of inactivated vaccines, H9N2 AIVs remain dominant in chicken flocks. We demonstrated that inactivated vaccines did not prevent the replication of H9N2 AIVs in the upper airway of vaccinated chickens. Viral transmission was enhanced during sequential passage in vaccinated chickens, which was attributed to the restricted production of defective interfering particles and the introduction of stable mutations (NP-N417D, M1-V219I, and NS1-R140W) which enhanced viral replication. Notably, the genetic diversity of H9N2 AIVs was greater and included more potential mammal/human-adapted mutations after passage through vaccinated chickens than through naïve chickens, which might facilitate the emergence of mammal-adapted strains. By contrast, vaccines inducing cellular/mucosal immunity in the upper respiratory tract effectively limit H9N2 AIV. These findings highlight the limitations of inactivated vaccines and the need for revised vaccination strategies to control H9N2 AIV.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
NPJ Vaccines
NPJ Vaccines Immunology and Microbiology-Immunology
CiteScore
11.90
自引率
4.30%
发文量
146
审稿时长
11 weeks
期刊介绍: Online-only and open access, npj Vaccines is dedicated to highlighting the most important scientific advances in vaccine research and development.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信